Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

US-friendly broker Finpari

 

Enter Stock Symbol:  

Atyr Pharma Inc (LIFE)

3.725 +0.050 (+1.361%)

6/22/2017  12:04pm

Open:

3.700

Pre. Close:

3.675

High:

3.750

Low:

3.550

Volume:

16,561

Market Cap:

88.68M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

3.86 - 3.89

3.89 - 3.95

Low:

3.39 - 3.41

3.41 - 3.44

Close:

3.57 - 3.68

3.68 - 3.87

Technical analysis  (as of: 2017-06-21 4:33:38 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 4.32     One year: 5.05

Support:

Support1: 3.36    Support2: 3.15

Resistance:

Resistance1: 3.70    Resistance2: 4.32

Pivot:

3.44

Moving Averages:

MA(5): 3.55     MA(20): 3.45

MA(100): 3.38     MA(250): 3.13

MACD:

MACD(12,26): 0.07     Signal(12,26,9): 0.05

%K %D:

%K(14,3): 98.48     %D(3): 90.85

RSI:

RSI(14): 63.46

52-Week:

High: 4.450  Low: 2.100  Change(%): 32.2

Average Vol(K):

3-Month: 1496  10-Days 19

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
LIFE has closed below upper band by 3.1%. Bollinger Bands are 18.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 16 Mar 2017 20:08:24 GMT
aTyr Pharma Announces Fourth Quarter and Year-End 2016 Operating Results

Mon, 03 Apr 2017 12:00:00 GMT
aTyr Pharma Announces Appointment of Jeffery S. Hatfield to its Board of Directors

Wed, 10 Aug 2016 20:06:59 GMT
aTyr Pharma Announces Second Quarter 2016 Operating Results

Thu, 07 May 2015 01:30:00 GMT
San Diego's aTyr Pharma Raises Total Proceeds of $75M in IPO

Wed, 30 Mar 2016 20:01:58 GMT
aTyr Pharma Appoints Sanjay Shukla, MD, MS, as Chief Medical Officer

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

23.81

Shares Float (M)

10.92

% Held by Insiders

9.43

% Held by Institutions

60.80

Shares Short (K)

555

Shares Short Prior Month (K)

545

Stock Financials

EPS

-2.330

EPS Est. Current Year

-2.180

EPS Est. Next Year

-2.310

EPS Est. Next Quarter

-0.600

Forward EPS

1.#IO

Book Value (p.s.)

2.130

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-38.0

Return on Equity (ttm)

-73.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-2.274

Qtrly Earnings Growth

Operating Cash Flow (M)

-54.28

Levered Free Cash Flow (M)

-33.53

FoxReading.com

Valuation

P/E

-1.58

P/E Growth Ratio

0.02

P/BV

1.73

P/S

P/CF

-1.61

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

2

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.